A new partnership between Thomas Jefferson University and Sempresto, Inc. is positioning a next-generation epinephrine autoinjector to reshape how millions of severe allergy patients ...
The SaaS market is really taking off, and if you’re running a company in this space, you know it’s a wild ride. With so much ...